Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

16.52 +0.51 (+3.19%)

Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape

October 07, 2026

From Insulin Management To Cell Replacement: The Diabetes Revolution Is Accelerating New York, NY – October 7, 2026 – Diabetes cell therapy is moving into a very different phase. For years, the idea of...

Via FinancialNewsMedia

Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026

October 01, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks

September 29, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets

September 28, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know

September 23, 2026

What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...

Via StockStory

3 Cash-Burning Stocks with Questionable Fundamentals

September 18, 2026

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...

Via StockStory

Topics Electric Vehicles

3 Reasons TNDM is Risky and 1 Stock to Buy Instead

August 25, 2026

Over the last six months, Tandem Diabetes’s shares have sunk to $22.45, producing a disappointing 13.7% loss - a stark contrast to the S&P 500’s 10.5% gain. ...

Via StockStory

Topics Stocks

Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi ↗

August 18, 2026

Tandem Diabetes Care (NASDAQ:TNDM) highlighted its plans to expand insulin pump adoption through a shift to pharmacy distribution in the U.S., direct sales in additional international markets and...

Via MarketBeat

Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Pump shipments surged 10% as pharmacy adoption accelerated.

Via The Motley Fool

Topics Earnings

5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call

August 13, 2026

Tandem Diabetes met Wall Street’s revenue and profit expectations in Q2, but the market responded negatively, likely reflecting investor caution around the p...

Via StockStory

Topics Earnings

Why Tandem Diabetes (TNDM) Stock Is Trading Up Today

August 07, 2026

What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 18.2% in the afternoon session after the company reported seco...

Via StockStory

Topics Artificial Intelligence

Tandem Diabetes Care Q2 Earnings Call Highlights ↗

August 07, 2026

Tandem Diabetes Care (NASDAQ:TNDM) reported second-quarter results that included record sales, pump shipments and gross margin for a second quarter, while management highlighted early progress in its...

Via MarketBeat

Topics Earnings

TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery

August 07, 2026

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $254.6...

Via StockStory

Topics Economy

Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

August 06, 2026

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $254.6...

Via StockStory

Topics Artificial Intelligence

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

August 06, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Earnings: What To Look For From TNDM

August 04, 2026

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be announcing earnings results this Thursday after market close. Here’s what you need to ...

Via StockStory

Topics Artificial Intelligence

Tandem Diabetes Care Announces Upcoming Conference Presentation

July 28, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

3 Stocks Under $50 We Steer Clear Of

July 27, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

3 Healthcare Stocks with Questionable Fundamentals

July 23, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron...

Via StockStory

Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities

July 21, 2026

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:NVO),(NASDAQ:SNY),(NASDAQ:DXCM),(NASDAQ:TNDM) EQNX::TICKER_END

Via FinancialNewsMedia

1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges

July 17, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

July 15, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ...

Via StockStory

1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down

July 09, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets

July 01, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Why Tandem Diabetes (TNDM) Shares Are Sliding Today

June 30, 2026

What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 2.5% in the afternoon session after a new competitor, Modular Me...

Via StockStory

Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026

June 30, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

1 Mooning Stock with Impressive Fundamentals and 2 We Find Risky

June 19, 2026

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...

Via StockStory

Topics Stocks

Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q1 Earnings?

June 16, 2026

Tandem Diabetes has gotten torched over the last six months - since December 2025, its stock price has dropped 25.8% to $16.77 per share. This may have inves...

Via StockStory

Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

June 05, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Why Is Tandem Diabetes (TNDM) Stock Soaring Today

June 01, 2026

What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 13.8% in the afternoon session after Wells Fargo analysts upgr...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.